Express News | Shares of Cannabis-linked Stocks Are Trading Higher After Chris Christie in a Benzinga Exclusive Suggested He Thinks Trump May Attempt to Change Marijuana to a Non-scheduled Drug That Wouldn't Be Illegal
Canopy Growth Corp (CGC) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and ...
Canopy Growth Reports Mixed Q2 FY2025 Results
Health Care Up on Another Round of Mixed Earnings -- Health Care Roundup
Toronto Stocks Pull Back, Telus Shares Rise on 3Q Beat
Piper Sandler Underweight Canopy Growth
Canopy Growth 2Q Revenue Miss Due to Wana Supply Issue -- Market Talk
Express News | Canopy Growth Shares Are Trading Lower. The Company Reported Q2 Financial Results
Canopy Growth Corporation (CGC) Q2 2025 Earnings Call Transcript
Green Thumb Industries Looks Past 'Tricky Time' for Cannabis Stocks as the Company Notches Another Profit
Canopy Growth Shares Drop as Canadian Adult-Use Cannabis Drags Total Revenue in 2Q
Canopy Growth Q2 Loss Narrows on Storz & Bickel Net Revenue Boost
Canopy Growth Sees Positive Earnings Ahead Thanks to Cost Savings
Canopy Growth Loss Narrows While Revenue Falls in 2Q
Canopy Growth in Charts: Canada Cannabis Net Revenue Fell ~5% Y/Y in FQ2, Storz & Bickel +32%
Earnings Snapshot: Canopy Growth FQ2 Revenue Falls, Adjusted EBITDA Loss Narrows
Canopy Growth: Well Positioned to Accelerate Momentum in the 2H of Our Fiscal Yr >CGC
Canopy Growth: Solid 2Q Led by Strong Growth Across Storz & Bickel, Canadian Medical, and European Cannabis Businesses >CGC
Canopy Growth 2Q Loss/Shr C$1.48 >CGC
Canopy Growth GAAP EPS of -C$1.52, Revenue of C$73.96M
No Data